Try our beta test site

of PATient Education Related to CV Risk factOrs in Type 2 Diabetes Mellitus(Patrol). (DART)

This study has been completed.
Sponsor:
Information provided by:
AstraZeneca
ClinicalTrials.gov Identifier:
NCT00925717
First received: June 19, 2009
Last updated: January 25, 2010
Last verified: January 2010

June 19, 2009
January 25, 2010
May 2009
Not Provided
Investigate LDL-C goal achievement rate according to ADA recommendation [ Time Frame: Within the last 6 months from the date of data entry. ]
Same as current
Complete list of historical versions of study NCT00925717 on ClinicalTrials.gov Archive Site
Investigate reduction of 10-year risk for CHD by using UKPDS risk engine [ Time Frame: Within the last 6 months from the date of data entry. ]
Same as current
Not Provided
Not Provided
 
of PATient Education Related to CV Risk factOrs in Type 2 Diabetes Mellitus(Patrol).
of PATient Education Related to CV Risk factOrs in Type 2 Diabetes Mellitus(Patrol).
An observational, non-interventional, multi-centre study to provide further information on the utility of test for a predictive marker by investigating the current prevalence of high sensitivity CRP (hs-CRP) testing and characteristics of each CVD risk group.
Not Provided
Observational
Observational Model: Cohort
Time Perspective: Retrospective
Not Provided
Not Provided
Non-Probability Sample
Who have records of clinic visit with endocrine internal medicines of nationwide secondary/tertiary hospitals within the last six months.
Low Density Lipoprotein Cholesterol Goal Achievement
Not Provided
2500 patients
Who have records of clinic visit with endocrine internal medicines of nationwide secondary/tertiary hospitals within the last six months.
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
4045
October 2009
Not Provided

Inclusion Criteria:

  • Subjects who was diagnosed as diabetes
  • Subjects who was diagnosed as dyslipidaemia or takes lipid lowering medication
  • Clinic visit in the past 6 months more than once

Exclusion Criteria:

  • Subjects who are unwilling or unable to provide their examination and lab result of medical chart.
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Korea, Republic of
 
 
NCT00925717
NIS-CKR-DUM-2009/1
No
Not Provided
Not Provided
Not Provided
Hyunah Caroline, Choi / CV TA Physician, AstraZeneca Pharmaceuticals
AstraZeneca
Not Provided
Study Director: MoonGyu Lee, Ph.D. Samsung Medical Center
AstraZeneca
January 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP